Improving clinical outcomes in patients with methicillin-sensitive staphylococcus aureus bacteremia and reported penicillin allergy

Clinical Infectious Diseases

Volumn 61, Issue 5, 2015, Pages 741-749

  Blumenthal, Kimberly G ^a,b,c   Parker, Robert A ^b,c   Shenoy, Erica S ^b,c,d   Walensky, Rochelle P ^b,c  

^a Allergy and Rheumatology Center   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

^d Infection Control Unit   (United States)

Author keywords

Allergy; Decision analysis; Penicillin; Staphylococcus aureus; Vancomycin

Indexed keywords

CEFAZOLIN; PENICILLIN DERIVATIVE; VANCOMYCIN; ANTIINFECTIVE AGENT;

ADVERSE DRUG REACTION; ARTICLE; DRUG EFFICACY; DRUG HYPERSENSITIVITY; DRUG SENSITIVITY; HUMAN; METHICILLIN SENSITIVE STAPHYLOCOCCUS AUREUS BACTEREMIA; METHICILLIN SUSCEPTIBLE STAPHYLOCOCCUS AUREUS; OUTCOME ASSESSMENT; PENICILLIN ALLERGY; PRIORITY JOURNAL; RECURRENT DISEASE; SENSITIVITY ANALYSIS; SKIN TEST; STAPHYLOCOCCAL BACTEREMIA; BACTEREMIA; BIOLOGICAL MODEL; CLINICAL DECISION SUPPORT SYSTEM; COMPLICATION; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MICROBIOLOGY; STAPHYLOCOCCAL INFECTIONS; STATISTICAL MODEL; TREATMENT OUTCOME;

ANTI-BACTERIAL AGENTS; BACTEREMIA; DECISION SUPPORT SYSTEMS, CLINICAL; DRUG HYPERSENSITIVITY; HUMANS; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; MODELS, BIOLOGICAL; MODELS, STATISTICAL; PENICILLINS; STAPHYLOCOCCAL INFECTIONS; TREATMENT OUTCOME;

EID: 84942036367     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/cid/civ394     Document Type: Article

References (66)

1. Reed SD, Friedman JY, Engemann JJ, et al. Costs and outcomes among hemodialysis-dependent patients with methicillin-resistant or methicillin-susceptible Staphylococcus aureus bacteremia. Infec Control Hosp Epidemiol 2005; 26:175-83.
2. Naidoo R, Nuttall J, Whitelaw A, Eley B. Epidemiology of Staphylococcus aureus bacteraemia at a tertiary children's hospital in Cape Town, South Africa. PLoS One 2013; 8:e78396.
3. Van Hal SJ, Jenson SO, Vaska VL, Espedido BA, Paterson DL, Gosbell IB. Predictors of mortality in Staphylococcus aureus bacteremia. Clin Microbiol Rev 2012; 25:362-86.
4. Cosgrove SE, Sakoulas G, Perencevich EN, Schwaber MJ, Karchmer AW, Carmeli Y. Comparison of mortality associated with methicillinresistant and methicillin-susceptible Staphylococcus aureus bacteremia: a meta-analysis. Clin Infect Dis 2003; 39:53-9.
5. Fowler VG, Sexton DJ. Clinical approach to Staphylococcus aureus bacteremia in adults. In: UpToDate, Baron EL, ed. Waltham, MA: UpToDate, 2013. Accessed 27 May 2015.
6. Bai AD, Showler A, Burry L, et al. Impact of infectious disease consultation on quality of care, mortality, and length of stay in Staphylococcus aureus bacteremia: results from a large multicenter cohort study. Clin Infect Dis 2015; 60:1451-61.
7. Stryjewski ME, Szcech LA, Benjamin DK, et al. Use of vancomycin or first generation cephalosporins for the treatment of hemodialysis dependent patients with methicillin-susceptibile Staphylococcus aureus bacteremia. Clin Infect Dis 2006; 44:190-6.
8. Kim EK, Oh M, Choe K, Kim S, Kim K, Kim H. Outcome of vancomycin treatment in patients with methicillin-susceptible Staphylococcus aureus bacteremia. Antimicrob Agents Chemother 2008; 52:192.
9. González C, Rubio M, Romero-Vivas J, González M, Picazo JJ. Bacteremic pneumonia due to Staphylococcus aureus: a comparison of disease caused by methicillin-resistant and methicillin-susceptible organisms. Clin Infect Dis 1999; 29:1171-7.
10. Mylotte JM, McDermott C, Spooner JA. Prospective study of 114 consecutive episodes of Staphylococcus aureus bacteremia. Rev Infect Dis 1987; 9:891-907.
11. McDanel JS, Perencevich EN, Diekema DJ, et al. Comparative effectiveness of beta-lactams versus vancomycin for treatment of methicillinsusceptible Staphylococcus aureus bloodstream infections among 122 hospitals. Clin Infect Dis 2015; 61:361-7.
12. Fowler VG, Kong LK, Corey GR, et al. Recurrent Staphylococcus aureus bacteremia: pulsed-field gel electrophoresis findings in 29 patients. J Infect Dis 1999; 179:1157.
13. LaPlante KL, Rybak MJ. Impact of high-inoculum Staphylococcus aureus on the activities of nafcillin, vancomycin, linezolid, and daptomycin, alone and in combination with gentamicin, in an in vitro pharmacodynamic model. Antimicrob Agents Chemother 2004; 48:4665-72.
14. Liu C, Bayer A, Cosgrove SE, et al. Clinical practice guidelines by the Infectious Diseases Society of America for the treatment of methicillinresistant Staphylococcus aureus infections in adults and children. Clin Infect Dis 2011; 52:1-38.
15. Chang FY, Peacock JE Jr, Musher DM, et al. Staphylococcus aureus bacteremia: recurrence and the impact of antibiotic treatment in a prospective multicenter study. Medicine 2003; 82:333-9.
16. Schweizer ML, Furuno J, Harris AD, et al. Comparative effectiveness of nafcillin or cefazolin versus vancomycin in methicillin-susceptible Staphylococcus aureus bacteremia. BMC Infect Dis 2011; 11:1-7.
17. Solensky R, Khan D. Drug allergy: an updated practice parameter. Ann Allergy Asthma Immunol 2010; 105:259-73.
18. Picard M, Begin P, Bouchard H, et al. Treatment of patients with a history of penicillin allergy in a large tertiary care academic hospital. J Allergy Clin Immunol Pract 2013; 1:252-7.
19. Lee CE, Zembower TR, Fotis MA, et al. The incidence of antimicrobial allergies in hospitalized patients: implication regarding prescribing patters and emerging bacterial resistance. Arch Inter Med 2000; 160:2819-22.
20. Arroliga ME, Wagner W, Bobek MB, Hoffman-Hogg L, Gordon SM, Arroliga AC. A pilot study of penicillin skin testing in patients with a history of penicillin allergy admitted to the medical ICU. Chest 2000; 118:1106-8.
21. Rimawi RH, Cook PP, Gooch M, et al. The impact of penicillin skin testing on clinical practice and antimicrobial stewardship. J Hosp Med 2013; 8:341-5.
22. Macy E, Contreras R. Health care use and serious infection prevalence associated with penicillin "allergy" in hospitalized patients: a cohort study. J Allergy Clin Immunol 2014; 133:790-6.
23. Chan KE, Warren HS, Thadhani RI, et al. Prevalence and outcomes of antimicrobial treatment for Staphylococcus aureus bacteremia in outpatients with ESRD. J Am Soc Nephrol 2012; 23:1551-9.
24. del Real GA, Rose ME, Ramirez-Atamoros MT, et al. Penicillin skin testing in patients with a history of beta-lactam allergy. Ann Allergy Asthma Immunol 2007; 98:355-9.
25. Park M, Markus P, Matesic D, Li JT. Safety and effectiveness of a preoperative allergy clinic in decreasing vancomyin use in patients with a history of penicillin allergy. Ann Allergy Asthma Immunol 2006; 97:681-7.
26. Macy E, Ngor E. Safely diagnosing clinically significant penicillin allergy using only penicilloyl-poly-lysine. J Allergy Clin Immunol Pract 2013; 1:258-63.
27. Raja AS, Lindsell CJ, Bernstein JA, Codispoti CD, Moellman JJ. The use of penicillin skin testing to assess the prevalence of penicillin allergy in an emergency department setting. Ann Emerg Med 2009; 54:72-7.
28. Blanca M, Torres MJ, Garcia JJ, et al. Natural evolution of skin test sensitivity in patients allergic to beta-lactam antibiotics. J Allergy Clin Immunol 1999; 103(5 pt 1):918-24.
29. Stember RH. Prevalence of skin test reactivity in patients with convincing, vague, and unacceptable histories of penicillin allergy. Allergy Asthma Proc 2005; 26:59-64.
30. Solensky R, Earl HS, Gruchalla RS. Penicillin allergy: prevalence of vague history in skin test-positive patients. Ann Allergy Asthma Immunol 2000; 85:195-9.
31. Sogn DD, Evans RR, Shepherd GM, et al. Results of the National Institute of Allergy and Infectious Diseases Collaborative Clinical Trial to test the predictive value of skin testing with major and minor penicillin derivatives in hospitalized adults. Arch Int Med 1992; 152:1025-32.
32. Pichichero ME. A review of evidence supporting the American Academy of Pediatrics recommendation for prescribing cephalosporin antibiotics for penicillin-allergic patients. Pediatrics 2005; 115:1048-57.
33. Pichichero ME. Cephalosporins can be prescribed safely for penicillinallergic patients. J Fam Pract 2006; 55:106-12.
34. Pichichero ME. Use of selected cephalosporins in penicillin-allergic patients: a paradigm shift. Diagn Microbiol Infect Dis 2007; 57 (3 suppl):13S-8.
35. Pichichero ME, Casey JR. Safe use of selected cephalosporins in penicillin-allergic patients: a meta-analysis. Otolaryngol Head Neck Surg 2007; 36:340-7.
36. Kao L, Rajan J, Roy L, Kavosh E, Khan DA. Adverse reactions during drug challenges: a single US institution's experience. Ann Allergy Asthma Immunol 2013; 110:86-91.
37. Solensky R, Earl HS, Gruchalla RS. Clinical approach to penicillin-allergy patients: a survey. Ann Allergy Asthma Immunol 2000; 84:329-33.
38. Kohn LT, Corrigan JM, Donaldson MS, eds. To err is human: building a safer health system. Washington, DC: The National Academies Press, 2000.
39. Cavalcanti AB, Goncalves AR, Almeida CS, Bugano DD, Silva E. Teichoplanin versus vancomycin for proven or suspected infection. Cochrane Database Syst Rev 2010; CD007022.
40. Tice AD, Rehm SJ, Dalovisio JR, et al. Practice guidelines for outpatient parenteral antimicrobial therapy. Clin Infect Dis 2004; 38:1651-72.
41. Gadde J, Spence M, Wheeler B, Adkinson FJ. Clinical experience with penicillin skin testing in a large inner-city STD clinic. JAMA 1993; 270:2456-63.
42. Fox S, ParkMA. Penicillin skin testing in the evaluation and management of penicillin allergy. Ann Allergy Asthma Immunol 2011; 106:1-7.
43. Goodman EJ, Morgan MJ, Johnson PA, Nichols BA, Denk N, Gold BB. Cephalosporins can be given to penicillin-allergic patients who do not exhibit an anaphylactic response. J Clin Anesth 2001; 13:561-4.
44. Earl HS, Casey WC, Gruchalla RS. Safety of cephalosporin administration to patients with histories of penicillin allergy. J Allergy Clin Immunol 2004; 113:1220-2.
45. Sagar PS, Katelaris CH. Utility of penicillin skin testing in patients with a history of penicillin allergy. Asia Pac Allergy 2013; 3:115-99.
46. Ma L, Danoff TM, Borish L. Case fatality and population mortality associated with anaphylaxis in the United States. J Allergy Clin Immunol 2014; 133:1075-83.
47. Renaudin JM, Beaudouin E, Ponvert C, Demoly P, Moneret-Vautrin DA. Severe drug-induced anaphylaxis: analysis of 333 cases recorded by the Allergy Vigilance Network from 2002 to 2010. Allergy 2013; 68:929-37.
48. Ribiero-Vaz I, Marques J, Demoly P, Polonia J, Gomes ER. Drug-induced anaphylaxis: a decade of reporting to the Portugese Pharmacovigilance Authority. Eur J Clin Pharmacol 2013; 69:673-81.
49. Wang DY, Forslund C, Persson U, Wiholm BE. Drug-attributed anaphylaxis. Pharmacoepidemiol Drug Saf 1998; 7:269-74.
50. Kohno S, Yamaguchi K, Aikawa N, et al. Linezolid versus vancomycin for the treatment of infections caused by methicillin-resistant Staphylococcus aureus in Japan. J Antimicrob Chemother 2007; 60:1361-9.
51. Park MA, McClimon BJ, Ferguson B, et al. Collaboration between allergists and pharmacists increases beta-lactam antibiotic prescriptions in patients with a history of penicillin allergy. Int Arch Allergy Immunol 2011; 154:57-62.
52. Youngster I, Shenoy ES, Hooper DC, Nelson SB. Comparative evaluation of the tolerability of cefazolin and nafcillin for treatment of methicillin-susceptible Staphylococcus aureus infections in the outpatient setting. Clin Infect Dis 2014; 59:369-75.
53. Kuperman GJ, Marston E, Paterno M, et al. Creating an enterprise-wide allergy repository at Partners HealthCare System. AMIA Annu Symp Proc 2003; 2003:376-80.
54. Iammatteo M, Blumenthal KG, Saff R, Long AA, Banerji A. Safety and outcomes of test doses for the evaluation of adverse drug reactions: a 5-year retrospective review. J Allergy Clin Immunol Pract 2014; 2:768-74.
55. Blumenthal KG, Shenoy ES, Hurwitz S, Varughese CA, Hooper DC, Banerji A. Effect of a drug allergy educational program and antibiotic prescribing guideline on inpatient clinical providers' antibiotic prescribing knowledge. J Allergy Clin Immunol Pract 2014; 2:407-13.
56. Blumenthal KG, Patil SU, Long AA. The importance of vancomycin in drug rash eosinophilia and systemic symptoms (DRESS) syndrome. Allergy Asthma Proc 2012; 33:165-71.
57. Stevens DL, Herr D, Lampiris H, Hunt JL, Batts DH, Hafkin B. Linezolid versus vancomycin for the treatment of methicillin-resistant Staphylococcus aureus infections. Clin Infect Dis 2002; 34:1481-90.
58. An SY, Hwang EK, Kim JE, et al. Vancomycin-associated spontaneous cutaneous adverse drug reactions. Allergy Asthma Immunol Res 2011; 3:194-8.
59. Wallace MR, Mascola JR, Oldfield EC. Red man syndrome: incidence, etiology and prophylaxis. J Infect Dis 1991; 164:1180-5.
60. Faden D, Faden HS. The high rate of adverse drug events in children receiving prolonged outpatient parenteral antibiotic therapy for osteomyelitis. Pediatr Infect Dis 2009; 28:539-41.
61. Lee S, Choe PG, Song KH, et al. Is cefazolin inferior to nafcillin for treatment of methicillin-susceptible Staphylococcus aureus bacteremia? Antimicrob Agents Chemother 2011; 55:5122-6.
62. Paul M, Zemer-Wassercug N, Talker O, et al. Are all beta-lactams similarly effective in the treatment of methicillin-sensitive Staphylococcus aureus bacteraemia? Clin Microbiol Infect 2011; 17:1581-6.
63. Martone WJ, Lamp KC. Efficacy of daptomycin in complicated skin and skin-structure infections due to methicillin-sensitive and-resistant Staphylococcus aureus: results from the CORE Registry. Curr Med Res Opin 2006; 22:2337-43.
64. Sakoulas G, Brown J, Lamp KC, Friedrich LV, Lindfield KC. Clinical outcomes of patients receiving daptomycin for the treatment of Staphylococcus aureus infections and assessment of clinical factors for daptomycin failure: a retrospective cohort study utilizing the Cubicin Outcomes Registry and Experience. Clin Ther 2009; 31:1936-45.
65. Fowler VG Jr, Boucher HW, Corey GR, et al. Daptomycin versus standard therapy for bacteremia and endocarditis caused by Staphylococcus aureus. N Engl J Med 2006; 355:653-65.
66. Segreti JA, Crank CW, Finney MS. Daptomycin for the treatment of gram-positive bacteremia and infective endocarditis: a retrospective case series of 31 patients. Pharmacotherapy 2006; 26:347-52.